How Life Sciences Can Drive Innovation And Sustainability In Returns Management
Organizations have a unique opportunity to redefine returns management to enhance compliance, optimize operations and achieve ...
Bisnow8h
Gov. Shapiro Bets $30M On Pennsylvania Life Sciences Vying With Boston And The Bay Area
Now, Pennsylvania Gov. Josh Shapiro hopes to change that and take on the sector's top dogs with $30M allocated for life ...
4 publicly traded Philadelphia-area life sciences companies raise $34M
The successful financings come amid a more than two-year stretch when the sector has struggled to attract fresh capital with ...
I work in a research lab and know how to make science fun for kids. Here's how my family finds science in everyday life.
As a lab technician, I'm doing these four things — including turning bath time into a fun experiment — to get my young ...
Becton Dickinson looks to divest life sciences unit at $30 billion valuation, source says
U.S. medical device maker Becton Dickinson is considering a potential separation of its life sciences unit at a valuation of ...
ncbiotech.org2d
TEConomy report: NC life sciences growth outpaces nation, passes 100,000 job milestone
The life sciences industry has a significant impact on the North Carolina economy. Using data from NCBiotech’s life sciences ...
Business Facilities1d
CBRE Reports Examine Life Sciences Market
The sector benefitted last year from record-high life sciences employment in the U.S., a number of new drugs receiving ...
Gladstone poised to buy Mission Bay life sciences offices
Gladstone Institutes hopes to buy 103,400 square feet of life sciences research offices near its hub in San Francisco’s ...
The Scientist2d
Inventia Life Science Launches RASTRUMâ„¢ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research
Inventia Life Science, an innovator in 3D cell culture technologies, announces the launch of RASTRUMâ„¢ Allegro, a ...
Y-mAbs to Present at the Oppenheimer 35áµ—Ê° Annual Life Sciences Conference
About Y-mAbs Y-mAbs is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, radioimmunotherapy and antibody-based therapeutic cancer products. The ...